Novabay Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)14holders
$0.10avg. 13F price*
At the end of Q1 2024, 14 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings. The largest holders were UBS Group AG ($23K), Two Sigma Securities, LLC ($16K) and Geode Capital Management, LLC ($3K).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P300
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 8 | $227K |
Ownership 14 holders
| UBS Group AG | 0.00% | Add +2495.8% | 220,643 | $23K |
| Two Sigma Securities, LLC | 0.00% | Add +835.6% | 149,299 | $16K |
| Geode Capital Management, LLC | 0.00% | No change | 25,061 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +34.2% | 15,210 | $2K |
| Vanguard Group Inc. | 0.00% | No change | 13,710 | $1K |
| Zacks Investment Management | 0.00% | New | 10,000 | $1K |
| Morgan Stanley | 0.00% | No change | 158 | $17 |
| Bank of America Corp. | 0.00% | No change | 86 | $9 |
| Wells Fargo & Company | 0.00% | Add +2.0% | 51 | $5 |
| Osaic Holdings, Inc. | 0.00% | No change | 37 | $4 |
| Blue Trust, Inc. | 0.00% | No change | 37 | $4 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 12 | $1 |
| Addison Advisors LLC | 0.00% | No change | 4 | $1 |
| Royal Bank of Canada | 0.00% | No change | 15 | $0 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.